These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases. Oh DB BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178 [TBL] [Abstract][Full Text] [Related]
12. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases. Li M Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286 [TBL] [Abstract][Full Text] [Related]
13. Nanotechnology-based approaches for treating lysosomal storage disorders, a focus on Fabry disease. Abasolo I; Seras-Franzoso J; Moltó-Abad M; Díaz-Riascos V; Corchero JL; Pintos-Morell G; Schwartz S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1684. PubMed ID: 33314628 [TBL] [Abstract][Full Text] [Related]
14. Personalized Pharmacoperones for Lysosomal Storage Disorder: Approach for Next-Generation Treatment. Haneef SA; Doss CG Adv Protein Chem Struct Biol; 2016; 102():225-65. PubMed ID: 26827607 [TBL] [Abstract][Full Text] [Related]